This inventor holds 1 USPTO granted patent. Top assignee: Sawai Pharmaceutical Co., Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Hisaya Sangawa: Innovator in Pharmaceutical Microparticle Production
Introduction
Hisaya Sangawa is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the production of microparticles. His innovative approach has led to advancements in drug formulation and delivery.
Latest Patents
Hisaya Sangawa holds a patent for a process for the production of spherical microparticles comprising tamsulosin hydrochloride. The patent outlines a method that includes several steps: first, mixing and stirring tamsulosin hydrochloride, microcrystalline cellulose, and water until a uniform mixture is achieved. Next, the mixture is granulated using an stirring granulator with a specific peripheral speed. Finally, the granules are dried to produce the desired spherical fine particles. This invention also includes coated fine particles and an orally disintegrating tablet containing these coated particles.
Career Highlights
Sangawa is associated with Sawai Pharmaceutical Co., Ltd., where he has been instrumental in developing innovative pharmaceutical solutions. His work has contributed to the enhancement of drug delivery systems, making medications more effective and easier to administer.
Collaborations
Hisaya Sangawa has collaborated with notable colleagues such as Toshihiro Yanagi and Yoshitaka Iwakura. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical industry.
Conclusion
Hisaya Sangawa's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to improving drug formulation and delivery. His work continues to impact the industry positively, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
